Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
FRLN was delisted on the 16th of February, 2024.
20 hedge funds and large institutions have $217M invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 5 closing their positions.
40% more capital invested
Capital invested by funds: $155M → $217M (+$61.9M)
5.44% more ownership
Funds ownership: 27.85% → 33.29% (+5.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
9% less funds holding
Funds holding: 22 → 20 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$28.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.84M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.39M |
| 4 |
CA
CHI Advisors
New York
|
+$615K |
| 5 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$335K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$3.11M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$3.02M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
-$1.81M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.48M |
| 5 |
HP
Hound Partners
New York
|
-$1.09M |
FRLN Hedge Fund Activity: Q4 2020 in Review
20 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q4 2020, worth a combined $217M — up 40% from $155M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of FRLN and 3 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was Novo Holdings A/S, adding an estimated $28.4M. The largest seller was Sectoral Asset Management, cutting an estimated $3.11M.
- 20 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q4 2020, down from 22 in Q3 2020.
- Funds reported $217M of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q4 2020, up 40% quarter-over-quarter.
- 3 funds opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q4 2020 and 5 closed out, a net change of -2 holders.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares buyer in Q4 2020 was Novo Holdings A/S, an estimated $28.4M added.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q4 2020 was Sectoral Asset Management, an estimated $3.11M sold.
Based on aggregated 13F filings for Q4 2020.